Post-ischemic hyperglycemia exacerbates the development of cerebral ischemic neuronal damage through the cerebral sodium-glucose transporter

Brain Research

Volumn 1489, Issue , 2012, Pages 113-120

  Yamazaki, Yui ^a   Harada, Shinichi ^a   Tokuyama, Shogo ^a  

^a KOBE GAKUIN UNIVERSITY   (Japan)

Author keywords

Cerebral ischemia; Glucose transporter; Hyperglycemia; Neuroprotection; SGLT

Indexed keywords

GLUCOSE; SODIUM GLUCOSE COTRANSPORTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; MALE; MOUSE; NERVE CELL LESION; NONHUMAN; POSTISCHEMIC HYPERGLYCEMIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; ANIMALS, OUTBRED STRAINS; BLOOD GLUCOSE; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSE; GLUCOSE INTOLERANCE; HYPERGLYCEMIA; INFARCTION, MIDDLE CEREBRAL ARTERY; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; NEURONS; PHLORHIZIN; SODIUM-GLUCOSE TRANSPORTER 1; STRESS, PHYSIOLOGICAL;

MUS;

EID: 84869487801     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2012.10.020     Document Type: Article

References (31)

1. A. Benchoua, C. Guegan, C. Couriaud, H. Hosseini, N. Sampaio, D. Morin, and B. Onteniente Specific caspase pathways are activated in the two stages of cerebral infarction J. Neurosci. 21 2001 7127 7134
2. D. Burdakov, S.M. Luckman, and A. Verkhratsky Glucose-sensing neurons of the hypothalamus Philos. Trans. R. Soc. Lond. B: Biol. Sci. 360 2005 2227 2235
3. G.N. Costa, J. Vindeirinho, C. Cavadas, A.F. Ambrosio, and P.F. Santos Contribution of TNF receptor 1 to retinal neural cell death induced by elevated glucose Mol. Cell. Neurosci. 50 2012 113 123
4. A. Diez-Sampedro, B.A. Hirayama, C. Osswald, V. Gorboulev, K. Baumgarten, C. Volk, E.M. Wright, and H. Koepsell A glucose sensor hiding in a family of transporters Proc. Nat. Acad. Sci. U.S.A. 100 2003 11753 11758
5. U. Dirnagl, C. Iadecola, and M.A. Moskowitz Pathobiology of ischaemic stroke: an integrated view Trends Neurosci. 22 1999 391 397
6. J.R. Ehrenkranz, N.G. Lewis, C.R. Kahn, and J. Roth Phlorizin: a review Diabetes Metab. Res. Rev. 21 2005 31 38
7. B. Fuentes, J. Castillo, B. San Jose, R. Leira, J. Serena, J. Vivancos, A. Davalos, A.G. Nunez, J. Egido, and E. Diez-Tejedor The prognostic value of capillary glucose levels in acute stroke: the GLycemia in acute stroke (GLIAS) study Stroke 40 2009 562 568
8. Z. Glick, and J. Mayer Hyperphagia caused by cerebral ventricular infusion of phloridzin Nature 219 1968 1374
9. S. Harada, W.H. Fujita, K. Shichi, and S. Tokuyama The development of glucose intolerance after focal cerebral ischemia participates in subsequent neuronal damage Brain Res. 1279 2009 174 181
10. S. Harada, W. Hamabe, K. Kamiya, T. Satake, J. Yamamoto, and S. Tokuyama Preventive effect of Morinda citrifolia fruit juice on neuronal damage induced by focal ischemia Biol. Pharm. Bull. 32 2009 405 409
11. S. Harada, W. Fujita-Hamabe, and S. Tokuyama The importance of regulation of blood glucose levels through activation of peripheral 5′-AMP-activated protein kinase on ischemic neuronal damage Brain Res. 1351 2010 254 263
12. S. Harada, W. Fujita-Hamabe, and S. Tokuyama Effect of orexin-A on post-ischemic glucose intolerance and neuronal damage J. Pharmacol. Sci. 115 2011 155 163
13. S. Harada, W. Fujita-Hamabe, and S. Tokuyama Ischemic stroke and glucose intolerance: a review of the evidence and exploration of novel therapeutic targets J. Pharmacol. Sci. 118 2012 1 13
14. W.N. Kernan, C.M. Viscoli, S.E. Inzucchi, L.M. Brass, D.M. Bravata, G.I. Shulman, and J.C. McVeety Prevalence of abnormal glucose tolerance following a transient ischemic attack or ischemic stroke Arch. Intern. Med. 165 2005 227 233
15. R.K. Kinne, and F. Castaneda SGLT inhibitors as new therapeutic tools in the treatment of diabetes Handb. Exp. Pharmacol. 2011 105 126
16. S. Malatiali, I. Francis, and M. Barac-Nieto Phlorizin prevents glomerular hyperfiltration but not hypertrophy in diabetic rats Exp. Diabetes Res. 2008 2008 305403
17. K. Matz, K. Keresztes, C. Tatschl, M. Nowotny, A. Dachenhausenm, M. Brainin, and J. Tuomilehto Disorders of glucose metabolism in acute stroke patients: an underrecognized problem Diabetes Care 29 2006 792 797
18. J.W. McDonald, S.P. Althomsons, K.L. Hyrc, D.W. Choi, and M.P. Goldberg Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity Nat. Med. 4 1998 291 297
19. K.H. Moley, M.M. Chi, C.M. Knudson, S.J. Korsmeyer, and M.M. Mueckler Hyperglycemia induces apoptosis in pre-implantation embryos through cell death effector pathways Nat. Med. 4 1998 1421 1424
20. E. Morikawa, H. Mori, Y. Kiyama, M. Mishina, T. Asano, and T. Kirino Attenuation of focal ischemic brain injury in mice deficient in the epsilon1 (NR2A) subunit of NMDA receptor J. Neurosci. 18 1998 9727 9732
21. T. Nakase, S. Fushiki, and C.C. Naus Astrocytic gap junctions composed of connexin 43 reduce apoptotic neuronal damage in cerebral ischemia Stroke 34 2003 1987 1993
22. D. O'Malley, F. Reimann, A.K. Simpson, and F.M. Gribble Sodium-coupled glucose cotransporters contribute to hypothalamic glucose sensing Diabetes 55 2006 3381 3386
23. D.E. Pellegrini-Giampietro, J.A. Gorter, M.V. Bennett, and R.S. Zukin The GluR2 (GluR-B) hypothesis: Ca(2+)-permeable AMPA receptors in neurological disorders Trends Neurosci. 20 1997 464 470
24. G. Perez Lopez, O. Gonzalez Albarran, and M. Cano Megias Sodium-glucose cotransporter type 2 inhibitors (SGLT2): from familial renal glucosuria to the treatment of type 2 diabetes mellitus Nefrologia 30 2010 618 625
25. R. Poppe, U. Karbach, S. Gambaryan, H. Wiesinger, M. Lutzenburg, M. Kraemer, O.W. Witte, and H. Koepsell Expression of the Na+-d-glucose cotransporter SGLT1 in neurons J. Neurochem. 69 1997 84 94
26. I. Saito Epidemiological evidence of type 2 diabetes mellitus, metabolic syndrome, and cardiovascular disease in Japan Circ. J. 76 2012 1066 1073
27. A. Scheepers, H.G. Joost, and A. Schurmann The glucose transporter families SGLT and GLUT: molecular basis of normal and aberrant function JPEN J. Parenter. Enteral. Nutr. 28 2004 364 371
28. Y. Shimmyo, T. Kihara, A. Akaike, T. Niidome, and H. Sugimoto Three distinct neuroprotective functions of myricetin against glutamate-induced neuronal cell death: involvement of direct inhibition of caspase-3 J. Neurosci. Res. 86 2008 1836 1845
29. A. Shuaib, K.R. Lees, P. Lyden, J. Grotta, A. Davalos, S.M. Davis, H.C. Diener, T. Ashwood, W.W. Wasiewski, and U. Emeribe NXY-059 for the treatment of acute ischemic stroke N. Engl. J. Med. 357 2007 562 571
30. E.M. Wright, and E. Turk The sodium/glucose cotransport family SLC5 Pflugers Arch. 447 2004 510 518
31. L. Zhou, F. Li, H.B. Xu, C.X. Luo, H.Y. Wu, M.M. Zhu, W. Lu, X. Ji, Q.G. Zhou, and D.Y. Zhu Treatment of cerebral ischemia by disrupting ischemia-induced interaction of nNOS with PSD-95 Nat. Med. 16 2010 1439 1443